Change search
Link to record
Permanent link

Direct link
Publications (10 of 40) Show all publications
Håkansson, J., Juhlin, O., Hovannisyan, A., Rosendahl, J., Bogestål, Y. & Olmarker, K. (2024). Changes in ion-channels in the dorsal root ganglion after exposure to autologous nucleus pulposus and TNF. A rat experimental study. Journal of Orthopaedics, 47, 23-27
Open this publication in new window or tab >>Changes in ion-channels in the dorsal root ganglion after exposure to autologous nucleus pulposus and TNF. A rat experimental study
Show others...
2024 (English)In: Journal of Orthopaedics, ISSN 0972-978X, E-ISSN 2589-9082, Vol. 47, p. 23-27Article in journal (Refereed) Published
Abstract [en]

Purpose: It is known that contact of nucleus pulposus with the dorsal root ganglion may induce changes in nerve conduction and pain behavior. It has also been suggested that the behavioristic changes are caused by changes in voltage-gated ion channels, which in turn have been upregulated by TNF. Such upregulations have previously been shown for NaV 1.8 and NaV 1.9. In this investigation, we expanded the number of studied ion channels after the application of nucleus pulposus or TNF. Methods: Following removal of the left L4-5 fact joint, a disc puncture was performed and the dorsal root ganglion was exposed to nucleus pulposus (n = 5) and TNF (n = 5). Operated rats without disc puncture served as sham (n = 5) and 5 non-operated (naïve) rats were included. After 24 h, the DRGs were harvested and analyzed by quantitative PCR on validated pre-spotted primer plates displaying genes for 90 voltage-gated ion channels. Results: It was evident that the changes in operated animals were separate from the naïve rats. It was also apparent that gene expression changes in rats with nucleus pulposus or TNF application showed similar trends and were also separated from sham-operated animals. Conclusion: The application of nucleus pulposus and TNF onto the DRG in rats induces comparable changes in gene expression of several ion channels. Since the changes induced by TNF and NP are similar, one might also suspect that TNF mediates the NP-induced changes. However, such a mechanism needs further investigation. © 2023 The Authors

Place, publisher, year, edition, pages
Reed Elsevier India Pvt. Ltd., 2024
National Category
Surgery
Identifiers
urn:nbn:se:ri:diva-68103 (URN)10.1016/j.jor.2023.11.012 (DOI)2-s2.0-85176950867 (Scopus ID)
Funder
AFA Insurance
Note

The institution of the corresponding author (KO) has received funding from AFA Insurance , Stockholm, Sweden.

Available from: 2023-12-07 Created: 2023-12-07 Last updated: 2024-08-14Bibliographically approved
Ranji, P., Jonasson, E., Andersson, L., Filges, S., Luna Santamaría, M., Vannas, C., . . . Ståhlberg, A. (2024). Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development. Journal of Translational Medicine, 22, Article ID 389.
Open this publication in new window or tab >>Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development
Show others...
2024 (English)In: Journal of Translational Medicine, E-ISSN 1479-5876, Vol. 22, article id 389Article in journal (Refereed) Published
Abstract [en]

Background: Myxoid liposarcoma (MLS) displays a distinctive tumor microenvironment and is characterized by the FUS::DDIT3 fusion oncogene, however, the precise functional contributions of these two elements remain enigmatic in tumor development. Methods: To study the cell-free microenvironment in MLS, we developed an experimental model system based on decellularized patient-derived xenograft tumors. We characterized the cell-free scaffold using mass spectrometry. Subsequently, scaffolds were repopulated using sarcoma cells with or without FUS::DDIT3 expression that were analyzed with histology and RNA sequencing. Results: Characterization of cell-free MLS scaffolds revealed intact structure and a large variation of protein types remaining after decellularization. We demonstrated an optimal culture time of 3 weeks and showed that FUS::DDIT3 expression decreased cell proliferation and scaffold invasiveness. The cell-free MLS microenvironment and FUS::DDIT3 expression both induced biological processes related to cell-to-cell and cell-to-extracellular matrix interactions, as well as chromatin remodeling, immune response, and metabolism. Data indicated that FUS::DDIT3 expression more than the microenvironment determined the pre-adipocytic phenotype that is typical for MLS. Conclusions: Our experimental approach opens new means to study the tumor microenvironment in detail and our findings suggest that FUS::DDIT3-expressing tumor cells can create their own extracellular niche.

Place, publisher, year, edition, pages
BioMed Central Ltd, 2024
Keywords
Animals; Cell Line, Tumor; Cell Proliferation; Cell-Free System; Extracellular Matrix; Gene Expression Regulation, Neoplastic; Humans; Liposarcoma, Myxoid; Mice; Oncogene Proteins, Fusion; RNA-Binding Protein FUS; Tissue Scaffolds; Tumor Microenvironment; eosin; growth arrest and DNA damage inducible protein 153; hematoxylin; HLA antigen; major histocompatibility antigen class 2; RNA binding protein FUS; FUS protein, human; FUS-DDIT3 fusion protein, human; oncogene fusion protein; RNA binding protein FUS; adipogenesis; animal cell; animal experiment; animal model; antigen presentation; Article; cell adhesion; cell culture; cell cycle; cell growth; cell infiltration; cell interaction; cell invasion; cell migration; cell proliferation; chromatin assembly and disassembly; controlled study; decellularization; down regulation; endocytosis; experimental model; extracellular matrix; female; functional enrichment analysis; gene expression; gene expression profiling; gene fusion; genetic transcription; glycolysis; histology; HT-1080 cell line; human; human cell; immune response; in vivo study; liquid chromatography-mass spectrometry; mass spectrometry; metabolism; mouse; myxosarcoma; nonhuman; nucleotide metabolism; oncogene; phenotype; protein expression; proteomics; RNA extraction; RNA sequencing; RNA synthesis; sarcoma cell; single cell RNA seq; tumor cell; tumor microenvironment; tumor xenograft; upregulation; animal; cell free system; chemistry; gene expression regulation; genetics; pathology; tumor cell line
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
urn:nbn:se:ri:diva-73289 (URN)10.1186/s12967-024-05211-w (DOI)2-s2.0-85191402673 (Scopus ID)
Funder
Stiftelsen Assar Gabrielssons fondRegion Västra GötalandSwedish Cancer Society, 2022-2080; 2022-2214Swedish Childhood Cancer Foundation, 2022-0030Swedish Research Council, 2021-01008; 2019-01273Vinnova, 2017-03737Sjöberg FoundationWilhelm och Martina Lundgrens Vetenskapsfond
Note

Open access funding provided by University of Gothenburg. This research was funded by Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Region Västra Götaland, Sweden; Swedish Cancer Society (2022-2080 and 2022-2214); Swedish Childhood Cancer Foundation (2022-0030); Swedish Research Council (2021-01008 and 2019-01273); the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (965065 and 965580) and Sweden's Innovation Agency (2017-03737); the Sjöberg Foundation and Wilhelm and Martina Lundgren Foundation for Scientific Research.

Available from: 2024-05-24 Created: 2024-05-24 Last updated: 2024-08-14Bibliographically approved
Sidstedt, M., Gynnå, A. H., Kiesler, K. M., Jansson, L., Steffen, C. R., Håkansson, J., . . . Hedman, J. (2024). Ultrasensitive sequencing of STR markers utilizing unique molecular identifiers and the SiMSen-Seq method. Forensic Science International: Genetics, 71, Article ID 103047.
Open this publication in new window or tab >>Ultrasensitive sequencing of STR markers utilizing unique molecular identifiers and the SiMSen-Seq method
Show others...
2024 (English)In: Forensic Science International: Genetics, ISSN 1872-4973, E-ISSN 1878-0326, Vol. 71, article id 103047Article in journal (Refereed) Published
Abstract [en]

Massively parallel sequencing (MPS) is increasingly applied in forensic short tandem repeat (STR) analysis. The presence of stutter artefacts and other PCR or sequencing errors in the MPS-STR data partly limits the detection of low DNA amounts, e.g., in complex mixtures. Unique molecular identifiers (UMIs) have been applied in several scientific fields to reduce noise in sequencing. UMIs consist of a stretch of random nucleotides, a unique barcode for each starting DNA molecule, that is incorporated in the DNA template using either ligation or PCR. The barcode is used to generate consensus reads, thus removing errors. The SiMSen-Seq (Simple, multiplexed, PCR-based barcoding of DNA for sensitive mutation detection using sequencing) method relies on PCR-based introduction of UMIs and includes a sophisticated hairpin design to reduce unspecific primer binding as well as PCR protocol adjustments to further optimize the reaction. In this study, SiMSen-Seq is applied to develop a proof-of-concept seven STR multiplex for MPS library preparation and an associated bioinformatics pipeline. Additionally, machine learning (ML) models were evaluated to further improve UMI allele calling. Overall, the seven STR multiplex resulted in complete detection and concordant alleles for 47 single-source samples at 1 ng input DNA as well as for low-template samples at 62.5 pg input DNA. For twelve challenging mixtures with minor contributions of 10 pg to 150 pg and ratios of 1–15% relative to the major donor, 99.2% of the expected alleles were detected by applying the UMIs in combination with an ML filter. The main impact of UMIs was a substantially lowered number of artefacts as well as reduced stutter ratios, which were generally below 5% of the parental allele. In conclusion, UMI-based STR sequencing opens new means for improved analysis of challenging crime scene samples including complex mixtures. © 2024 The Authors

Place, publisher, year, edition, pages
Elsevier Ireland Ltd, 2024
National Category
Bioinformatics (Computational Biology)
Identifiers
urn:nbn:se:ri:diva-72751 (URN)10.1016/j.fsigen.2024.103047 (DOI)2-s2.0-85189897942 (Scopus ID)
Note

We thank Froste Svensson for input on the bioinformatics pipeline and Nelly Gyll\u00F6 Lind and Markus Andr\u00E9 Soma for practical assistance in pre-studies. This study was funded by VINNOVA: Project title \u201CUltrak\u00E4nsliga analyser f\u00F6r b\u00E4ttre h\u00E4lsa och kriminalteknik (ULTRA-UDI)\u201D and reference number 2020\u201304141, and V\u00E4stra G\u00F6talandsregionen RUN 2021\u201300059. Anders St\u00E5hlberg was funded by Region V\u00E4stra G\u00F6taland; Swedish Cancer Society [22\u20132080]; Swedish Childhood Cancer Foundation [2022\u20130030]; Swedish Research Council [2021\u201301008]; the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement [965065]; Sweden's Innovation Agency [2018\u201300421, 2020\u201304141] and the Sj\u00F6berg Foundation. Points of view in this document are those of the NIST-affiliated authors and do not necessarily represent the official position or policies of the U.S. Department of Commerce. Certain equipment, instruments, software, or materials are identified in this paper to specify the experimental procedure adequately. Such identification is not intended to imply recommendation or endorsement of any product or service by NIST, nor is it intended to imply that the materials or equipment identified are necessarily the best available for the purpose. All work performed at NIST has been reviewed and approved by the U. S. National Institute of Standards and Technology Research Protections Office. This study was determined to be \u201Cnot human subjects research\u201D (often referred to as research not involving human subjects) as defined in U. S. Department of Commerce Regulations, 15 CFR 27, also known as the Common Rule (45 CFR 46, Subpart A), for the Protection of Human Subjects by the NIST Human Research Protections Office and therefore not subject to oversight by the NIST Institutional Review Board (MML-16\u20130080). All data handling performed in Sweden was done in accordance with approval no 2023\u201305921\u20131 from the Swedish Ethical Review Authority. A.S. is co-inventor of the SiMSen-Seq technology that is patent protected (U.S. Serial No.:15/552,618). A.S. declares stock ownership and is a board member in Tulebovaasta, Iscaff Pharma and SiMSen Diagnostics. G.J. declares employment and stock ownership in SiMSen Diagnostics.

Available from: 2024-05-16 Created: 2024-05-16 Last updated: 2024-08-14Bibliographically approved
Hui, I., Pasquier, E., Solberg, A., Agrenius, K., Håkansson, J. & Chinga Carrasco, G. (2023). Biocomposites containing poly(lactic acid) and chitosan for 3D printing: Assessment of mechanical, antibacterial and in vitro biodegradability properties. Journal of The Mechanical Behavior of Biomedical Materials, 147, Article ID 106136.
Open this publication in new window or tab >>Biocomposites containing poly(lactic acid) and chitosan for 3D printing: Assessment of mechanical, antibacterial and in vitro biodegradability properties
Show others...
2023 (English)In: Journal of The Mechanical Behavior of Biomedical Materials, ISSN 1751-6161, E-ISSN 1878-0180, Vol. 147, article id 106136Article in journal (Refereed) Published
Abstract [en]

New bone repair materials are needed for treatment of trauma- and disease-related skeletal defects as they still represent a major challenge in clinical practice. Additionally, new strategies are required to combat orthopedic device-related infections (ODRI), given the rising incidence of total joint replacement and fracture fixation surgeries in increasingly elderly populations. Recently, the convergence of additive manufacturing (AM) and bone tissue engineering (BTE) has facilitated the development of bone healthcare to achieve personalized three-dimensional (3D) scaffolds. This study focused on the development of a 3D printable bone repair material, based on the biopolymers poly(lactic acid) (PLA) and chitosan. Two different types of PLA and chitosan differing in their molecular weight (MW) were explored. The novel feature of this research was the successful 3D printing using biocomposite filaments composed of PLA and 10 wt% chitosan, with clear chitosan entrapment within the PLA matrix confirmed by Scanning Electron Microscopy (SEM) images. Tensile testing of injection molded samples indicated an increase in stiffness, compared to pure PLA scaffolds, suggesting potential for improved load-bearing characteristics in bone scaffolds. However, the potential benefit of chitosan on the biocomposite stiffness could not be reproduced in compression testing of 3D printed cylinders. The antibacterial assays confirmed antibacterial activity of chitosan when dissolved in acetic acid. The study also verified the biodegradability of the scaffolds, with a process producing an acidic environment that could potentially be neutralized by chitosan. In conclusion, the study indicated the feasibility of the proposed PLA/chitosan biocomposite for 3D printing, demonstrating adequate mechanical strength, antibacterial properties and biodegradability, which could serve as a new material for bone repair.

Place, publisher, year, edition, pages
Elsevier Ltd, 2023
Keywords
3D printing; Biodegradability; Biopolymers; Compression testing; Injection molding; Lactic acid; Repair; Scaffolds (biology); Scanning electron microscopy; Stiffness; Stiffness matrix; Tensile testing; 3-D printing; 3D-printing; Antibacterials; Biocomposite; Bone repair materials; In-vitro; Mechanical; Poly lactic acid; Poly(lactic acid); Property; Chitosan
National Category
Polymer Technologies
Identifiers
urn:nbn:se:ri:diva-67723 (URN)10.1016/j.jmbbm.2023.106136 (DOI)2-s2.0-85172305781 (Scopus ID)
Funder
The Research Council of Norway, 337610
Note

Norges forskningsråd

Available from: 2023-11-03 Created: 2023-11-03 Last updated: 2023-11-21Bibliographically approved
Chinga Carrasco, G., Pasquier, E., Solberg, A., Leirset, I., Stevanic Srndovic, J., Rosendahl, J. & Håkansson, J. (2023). Carboxylated nanocellulose for wound healing applications – Increase of washing efficiency after chemical pre-treatment and stability of homogenized gels over 10 months. Carbohydrate Polymers, 314, Article ID 120923.
Open this publication in new window or tab >>Carboxylated nanocellulose for wound healing applications – Increase of washing efficiency after chemical pre-treatment and stability of homogenized gels over 10 months
Show others...
2023 (English)In: Carbohydrate Polymers, ISSN 0144-8617, E-ISSN 1879-1344, Vol. 314, article id 120923Article in journal (Refereed) Published
Abstract [en]

To commercialize a biomedical product as a medical device, reproducibility of production and time-stability are important parameters. Studies of reproducibility are lacking in the literature. Additionally, chemical pre-treatments of wood fibres to produce highly fibrillated cellulose nanofibrils (CNF) seem to be demanding in terms of production efficiency, being a bottleneck for industrial upscaling. In this study, we evaluated the effect of pH on the dewatering time and washing steps of 2,2,6,6-Tetramethylpiperidinyloxy (TEMPO)-mediated oxidized wood fibres when applying 3.8 mmol NaClO/g cellulose. The results indicate that the method does not affect the carboxylation of the nanocelluloses, and levels of approximately 1390 μmol/g were obtained with good reproducibility. The washing time of a Low-pH sample was reduced to 1/5 of the time required for washing a Control sample. Additionally, the stability of the CNF samples was assessed over 10 months and changes were quantified, the most pronounced were the increase of potential residual fibre aggregates, reduction of viscosity and increase of carboxylic acid content. The cytotoxicity and skin irritation potential were not affected by the detected differences between the Control and Low-pH samples. Importantly, the antibacterial effect of the carboxylated CNFs against S. aureus and P. aeruginosa was confirmed. © 2023 The Authors

Place, publisher, year, edition, pages
Elsevier Ltd, 2023
Keywords
Antibacterial, Degradation, Hydrolysis, Nanocellulose, TEMPO-oxidized fibres, Wound dressings, Chemical stability, Fibers, Gels, Nanofibers, pH, Production efficiency, Washing, Wood, 2, 2, 6, 6-tetramethylpiperidinyloxy-oxidized fiber, Antibacterials, Cellulose nanofibrils, Chemical pre-treatment, Nano-cellulose, Reproducibilities, Washing efficiency, Woodfiber, Wound healing applications, Carboxylation
National Category
Paper, Pulp and Fiber Technology
Identifiers
urn:nbn:se:ri:diva-64385 (URN)10.1016/j.carbpol.2023.120923 (DOI)2-s2.0-85152907526 (Scopus ID)
Note

Correspondence Address: Chinga-Carrasco, G.; RISE, Norway; email: gary.chinga.carrasco@rise-pfi.no; Funding details: Norges Forskningsråd, 309178; Funding text 1: The authors thank the Research Council of Norway for funding (OxyPol project - “Oxygenated biopolymers for biomedical applications”, grant no. 309178 ). 

Available from: 2023-05-03 Created: 2023-05-03 Last updated: 2023-11-03Bibliographically approved
Håkansson, J., Jenndahl, L., Simonsson, S., Johansson, M. E., Larsson, K., Strehl, R. & Olsen Ekerhult, T. (2023). De- and recellularized urethral reconstruction with autologous buccal mucosal cells implanted in an ovine animal model. Biomedizinische Technik (Berlin. Zeitschrift), 68(5), 493
Open this publication in new window or tab >>De- and recellularized urethral reconstruction with autologous buccal mucosal cells implanted in an ovine animal model
Show others...
2023 (English)In: Biomedizinische Technik (Berlin. Zeitschrift), ISSN 1862-278X, E-ISSN 0013-5585, Vol. 68, no 5, p. 493-Article in journal (Refereed) Published
Abstract [en]

Patients with urethral stricture due to any type of trauma, hypospadias or gender dysphoria suffer immensely from impaired capacity to urinate and are in need of a new functional urethra. Tissue engineering with decellularization of a donated organ recellularized with cells from the recipient patient has emerged as a promising alternative of advanced therapy medicinal products. The aim of this pilot study was to develop an ovine model of urethral transplantation and to produce an individualized urethra graft to show proof of function in vivo. Donated urethras from ram abattoir waste were decellularized and further recellularized with autologous buccal mucosa epithelial cells excised from the recipient ram and expanded in vitro. The individualized urethral grafts were implanted by reconstructive surgery in rams replacing 2.5 ± 0.5 cm of the native penile urethra. After surgery optimization, three ram had the tissue engineered urethra implanted for one month and two out of three showed a partially regenerated epithelium. Further adjustments of the model are needed to achieve a satisfactory proof-of-concept; however, we interpret these findings as a proof of principle and a possible path to develop a functional tissue engineered urethral graft with de- and recellularization and regeneration in vivo after transplantation. 

Place, publisher, year, edition, pages
De Gruyter Open Ltd, 2023
Keywords
ATMP, buccal mucosa, decellularization, ovine model, recellularization, regenerative medicine, urethral stricture, Cell engineering, Cells, Cytology, Surgery, Tissue, Tissue regeneration, Animal model, Decellularized, In-vivo
National Category
Urology and Nephrology
Identifiers
urn:nbn:se:ri:diva-64335 (URN)10.1515/bmt-2022-0386 (DOI)2-s2.0-85151846769 (Scopus ID)
Note

 Funding details: VINNOVA, 2017–02130; Funding text 1: Research funding: This study was supported by VINNOVA project CAMP (Contract no. 2017–02130). This study was partly performed by funding from all partners involved with required co-financing.

Available from: 2023-04-21 Created: 2023-04-21 Last updated: 2024-06-07Bibliographically approved
Zhang, Y., Håkansson, J., Fan, Y., Andrén, O. C., San Jacinto García, J., Qin, L., . . . Malkoch, M. (2023). Dendritic Nanogels Directed Dual-Encapsulation Topical Delivery System of Antimicrobial Peptides Targeting Skin Infections. Macromolecular Bioscience, 23, Article ID 2200433.
Open this publication in new window or tab >>Dendritic Nanogels Directed Dual-Encapsulation Topical Delivery System of Antimicrobial Peptides Targeting Skin Infections
Show others...
2023 (English)In: Macromolecular Bioscience, ISSN 1616-5187, E-ISSN 1616-5195, Vol. 23, article id 2200433Article in journal (Refereed) Published
Abstract [en]

Antimicrobial peptides (AMPs) are promising antibacterial agents in the fight against multidrug resistant pathogens. However, their application to skin infections is limited by the absence of a realizable topical delivery strategy. Herein, a hybrid hierarchical delivery system for topical delivery of AMPs is accomplished through the incorporation of AMPs into dendritic nanogels (DNGs) and their subsequent embedding into poloxamer gel. The high level of control over the crosslink density and the number of chosen functionalities makes DNGs ideal capsules with tunable loading capacity for DPK-060, a human kininogen-derived AMP. Once embedded into the poloxamer gel, DPK-060 encapsulated in DNGs displays a slower release rate compared to those entrapped directly in the gels. In vitro EpiDerm Skin Irritation Tests show good biocompatibility, while MIC and time-kill curves reveal the potency of the peptide toward Staphylococcus aureus. Anti-infection tests on ex vivo pig skin and in vivo mouse infection models demonstrate that formulations with 0.5% and 1% AMPs significantly inhibit the growth of S. aureus. Similar outcomes are observed for an in vivo mouse surgical site infection model. Importantly, when normalizing the bacteria inhibition to released/free DPK-060 at the wound site, all formulations display superior efficacy compared to DPK-060 in solution. © 2023 The Authors. 

Place, publisher, year, edition, pages
John Wiley and Sons Inc, 2023
Keywords
antimicrobial peptide delivery, dendritic nanogel, DPK-060, poloxamer gel, Antimicrobial agents, Bacteria, Biocompatibility, Mammals, Nanostructured materials, Peptides, Antimicrobial peptide, Dendritics, Nanogels, Peptide delivery, Poloxamer, Topical delivery
National Category
Natural Sciences
Identifiers
urn:nbn:se:ri:diva-63994 (URN)10.1002/mabi.202200433 (DOI)2-s2.0-85146683018 (Scopus ID)
Note

Funding details: Knut och Alice Wallenbergs Stiftelse, 2012‐0196, 2017‐0300, 2019‐0002; Funding details: Vetenskapsrådet, VR, 2010–453; Funding details: Seventh Framework Programme, FP7, 60418; Funding details: Barncancerfonden, TJ2017‐0009; Funding text 1: The authors acknowledge the Knut och Alice Wallenberg Foundation (KAW) (Grant numbers: 2012‐0196, 2017‐0300, and 2019‐0002), the Seventh Framework Programme (Grant number: 60418), the Barncancerfonden (Grant number: TJ2017‐0009), and the Swedish Research Council (VR) (Grant number 2010–453) for financial support.

Available from: 2023-02-15 Created: 2023-02-15 Last updated: 2024-05-27Bibliographically approved
Rosendahl, J., Zarna, C., Håkansson, J. & Chinga-Carrasco, G. (2023). Gene-Expression Analysis of Human Fibroblasts Affected by 3D-Printed Carboxylated Nanocellulose Constructs. Bioengineering, 10(1), Article ID 121.
Open this publication in new window or tab >>Gene-Expression Analysis of Human Fibroblasts Affected by 3D-Printed Carboxylated Nanocellulose Constructs
2023 (English)In: Bioengineering, E-ISSN 2306-5354, Vol. 10, no 1, article id 121Article in journal (Refereed) Published
Abstract [en]

Three-dimensional (3D) printing has emerged as a highly valuable tool to manufacture porous constructs. This has major advantages in, for example, tissue engineering, in which 3D scaffolds provide a microenvironment with adequate porosity for cell growth and migration as a simulation of tissue regeneration. In this study, we assessed the suitability of three cellulose nanofibrils (CNF) that were obtained through 2,2,6,6-tetramethylpyperidine-1-oxyl (TEMPO)-mediated oxidation. The CNFs were obtained by applying three levels of carboxylation, i.e., 2.5, 3.8, and 6.0 mmol sodium hypochlorite (NaClO) per gram of cellulose. The CNFs exhibited different nanofibrillation levels, affecting the corresponding viscosity and 3D printability of the CNF gels (0.6 wt%). The scaffolds were manufactured by micro-extrusion and the nanomechanical properties were assessed with nanoindentation. Importantly, fibroblasts were grown on the scaffolds and the expression levels of the marker genes, which are relevant for wound healing and proliferation, were assessed in order to reveal the effect of the 3D-scaffold microenvironment of the cells. © 2023 by the authors.

Place, publisher, year, edition, pages
MDPI, 2023
Keywords
3D-printing, characterization, gene expression, nanocellulose, wound dressings
National Category
Biomaterials Science
Identifiers
urn:nbn:se:ri:diva-63992 (URN)10.3390/bioengineering10010121 (DOI)2-s2.0-85146750909 (Scopus ID)
Note

Funding details: 283895, 309178; Funding details: European Commission, EC; Funding details: Norges Forskningsråd, MNET17/NMCS-1204; Funding text 1: The authors acknowledge the European Commission and the Research Council of Norway for funding part of this work through the MANUNET III program (project no. MNET17/NMCS-1204), the MedIn project (grant no. 283895), “New functionalized medical devices for surgical interventions in the pelvic cavity” and the OxyPol project (“Oxygenated biopolymers for biomedical applications”, grant no. 309178).

Available from: 2023-02-15 Created: 2023-02-15 Last updated: 2023-05-22Bibliographically approved
Österberg, K., Bogestål, Y., Jenndahl, L., Gustafsson-Hedberg, T., Synnergren, J., Holmgren, G., . . . Håkansson, J. (2023). Personalized tissue-engineered veins - long term safety, functionality and cellular transcriptome analysis in large animals. Biomaterials Science, 11(11), 3860-3877
Open this publication in new window or tab >>Personalized tissue-engineered veins - long term safety, functionality and cellular transcriptome analysis in large animals
Show others...
2023 (English)In: Biomaterials Science, ISSN 2047-4830, E-ISSN 2047-4849, Vol. 11, no 11, p. 3860-3877Article in journal (Refereed) Published
Abstract [en]

Tissue engineering is a promising methodology to produce advanced therapy medicinal products (ATMPs). We have developed personalized tissue engineered veins (P-TEV) as an alternative to autologous or synthetic vascular grafts utilized in reconstructive vein surgery. Our hypothesis is that individualization through reconditioning of a decellularized allogenic graft with autologous blood will prime the tissue for efficient recellularization, protect the graft from thrombosis, and decrease the risk of rejection. In this study, P-TEVs were transplanted to vena cava in pig, and the analysis of three veins after six months, six veins after 12 months and one vein after 14 months showed that all P-TEVs were fully patent, and the tissue was well recellularized and revascularized. To confirm that the ATMP product had the expected characteristics one year after transplantation, gene expression profiling of cells from P-TEV and native vena cava were analyzed and compared by qPCR and sequencing. The qPCR and bioinformatics analysis confirmed that the cells from the P-TEV were highly similar to the native cells, and we therefore conclude that P-TEV is functional and safe in large animals and have high potential for use as a clinical transplant graft.

Place, publisher, year, edition, pages
NLM (Medline), 2023
Keywords
animal, endothelium cell, gene expression profiling, pig, procedures, tissue engineering, transplantation, vein, Animals, Endothelial Cells, Swine, Veins
National Category
Cell and Molecular Biology
Identifiers
urn:nbn:se:ri:diva-65415 (URN)10.1039/d2bm02011d (DOI)2-s2.0-85160870522 (Scopus ID)
Note

This study was supported by Vinnova project CAMP (contract no. 2017-02130), a common call by VINNOVA and Vetenskapsrådet: Biologcal pharmaseuticals (Dnr 2017-02983),by University of Skövde under grants from the Swedish Knowledge Foundation [#2016-0330, #2020-0014] and Västra Götalandsregionen (consultant check).

Available from: 2023-06-15 Created: 2023-06-15 Last updated: 2023-12-22Bibliographically approved
Pasquier, E., Rosendahl, J., Solberg, A., Ståhlberg, A., Håkansson, J. & Chinga Carrasco, G. (2023). Polysaccharides and Structural Proteins as Components in Three-Dimensional Scaffolds for Breast Cancer Tissue Models: A Review. Bioengineering, 10(6), Article ID 682.
Open this publication in new window or tab >>Polysaccharides and Structural Proteins as Components in Three-Dimensional Scaffolds for Breast Cancer Tissue Models: A Review
Show others...
2023 (English)In: Bioengineering, E-ISSN 2306-5354, Vol. 10, no 6, article id 682Article in journal (Refereed) Published
Abstract [en]

Breast cancer is the most common cancer among women, and even though treatments are available, efficiency varies with the patients. In vitro 2D models are commonly used to develop new treatments. However, 2D models overestimate drug efficiency, which increases the failure rate in later phase III clinical trials. New model systems that allow extensive and efficient drug screening are thus required. Three-dimensional printed hydrogels containing active components for cancer cell growth are interesting candidates for the preparation of next generation cancer cell models. Macromolecules, obtained from marine- and land-based resources, can form biopolymers (polysaccharides such as alginate, chitosan, hyaluronic acid, and cellulose) and bioactive components (structural proteins such as collagen, gelatin, and silk fibroin) in hydrogels with adequate physical properties in terms of porosity, rheology, and mechanical strength. Hence, in this study attention is given to biofabrication methods and to the modification with biological macromolecules to become bioactive and, thus, optimize 3D printed structures that better mimic the cancer cell microenvironment. Ink formulations combining polysaccharides for tuning the mechanical properties and bioactive polymers for controlling cell adhesion is key to optimizing the growth of the cancer cells. © 2023 by the authors.

Place, publisher, year, edition, pages
MDPI, 2023
Keywords
3D bioprinting, biopolymers, breast cancer models, cells microenvironment
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:ri:diva-65684 (URN)10.3390/bioengineering10060682 (DOI)2-s2.0-85163723963 (Scopus ID)
Note

Correspondence Address: G. Chinga-Carrasco; RISE PFI AS, Trondheim, Høgskoleringen 6b, NO-7491, Norway; E.P.: A.S. (Amalie Solberg), and G.C.-C. thank the Research Council of Norway and bioMAT4EYE project (Grant 337610) for funding part of this work. A.S. (Anders Ståhlberg) is funded by Region Västra Götaland, Swedish Cancer Society (2022-2080), Swedish Childhood Cancer Foundation (2022-0030), Swedish Research Council (2021-01008); the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (965065), Sweden’s Innovation Agency and the Sjöberg Foundation. J.H. and J.R. are funded by the Swedish Foundation for Strategic Research (FID15-0008), Sweden’s Innovation Agency (2017-03737 and 2021-04484) and Region Västra Götalandsregionen (RUN 2018-00017).

Available from: 2023-08-07 Created: 2023-08-07 Last updated: 2023-11-03Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-4270-8475

Search in DiVA

Show all publications